Showing 1 - 11 results of 11 for search 'Moynié, L', query time: 0.04s
Refine Results
-
1
Using the pimeloyl-CoA synthetase adenylation fold to synthesize fatty acid thioesters by Wang, M, Moynié, L, Harrison, P, Kelly, V, Piper, A, Naismith, J, Campopiano, D
Published 2017Journal article -
2
-
3
TonB-dependent receptor repertoire of pseudomonas aeruginosa for uptake of siderophore-drug conjugates by Luscher, A, Moynié, L, Auguste, P, Bumann, D, Mazza, L, Pletzer, D, Naismith, J, Köhler, T
Published 2018Journal article -
4
-
5
-
6
A key role for the periplasmic PfeE esterase in iron acquisition via the siderophore enterobactin in Pseudomonas aeruginosa by Perraud, Q, Moynié, L, Gasser, V, Munier, M, Godet, J, Hoegy, F, Mély, Y, Mislin, G, Naismith, J, Schalk, I
Published 2018Journal article -
7
MOMP from Campylobacter jejuni is a trimer of 18-stranded β-barrel monomers with a Ca(2+) ion bound at the constriction zone. by Ferrara, L, Wallat, G, Moynié, L, Dhanasekar, N, Aliouane, S, Acosta-Gutiérrez, S, Pagès, J, Bolla, J, Winterhalter, M, Ceccarelli, M, Naismith, J
Published 2016Journal article -
8
-
9
Covalent penicillin-protein conjugates elicit anti-drug antibodies that are clonally and functionally restricted by Deimel, LP, Moynié, L, Sun, G, Lewis, V, Turner, A, Buchanan, CJ, Burnap, SA, Kutuzov, M, Kobras, CM, Demyaneko, Y, Mohammed, S, Stracy, M, Struwe, WB, Baldwin, AJ, Naismith, J, Davis, BG, Sattentau, QJ
Published 2024Journal article -
10
Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2 by Huo, J, Le Bas, A, Ruza, RR, Duyvesten, HME, Mikolajek, H, Malinauskas, T, Tan, TK, Rijal, P, Dumoux, M, Ward, PN, Ren, J, Zhou, D, Harrison, PJ, Weckener, M, Clare, DK, Vogirala, VK, Radecke, J, Moynié, L, Zhao, Y, Gilbert-Jaramillo, J, Knight, ML, Tree, JA, Buttigieg, KR, Coombes, N, Elmore, MJ, Carroll, MW, Carrique, L, Shah, PNM, James, W, Townsend, AR, Stuart, DI, Owens, RJ, Naismith, JH
Published 2020Journal article -
11
A potent SARS-CoV-2 neutralising nanobody shows therapeutic efficacy in the Syrian golden hamster model of COVID-19 by Huo, J, Mikolajek, H, Le Bas, A, Clark, JJ, Sharma, P, Kipar, A, Dormon, J, Norman, C, Weckener, M, Clare, DK, Harrison, PJ, Tree, JA, Buttigieg, KR, Salguero, FJ, Watson, R, Knott, D, Carnell, O, Ngabo, D, Elmore, MJ, Fotheringham, S, Harding, A, Moynié, L, Ward, PN, Dumoux, M, Prince, T, Hall, Y, Hiscox, JA, Owen, A, James, W, Carroll, MW, Stewart, JP, Naismith, JH, Owens, RJ
Published 2021Journal article